The erroneous ruling by the CAFC in the Lovenox patent case in Jan 2012—which had the temporary effect of rendering drug-manufacturing patents unenforceable—has finally been reversed. Had the Court’s 2012 ruling stood, it would have eventually wreaked havoc on the US drug/biotech industry.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”